Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Carolyn Compton of NCI to Speak At Oncology Biomarkers Conference on January 27-28 San Diego, California - Carolyn Compton, will give a featured presentation on “Those Biomarkers Come from Biospecimens: Garbage In, Garbage Out” at GTCbio’s 3rd Oncology Biomarkers Conference on January
Carolyn Compton of NCI to Speak At Oncology Biomarkers Conference on January 27-28 San Diego, California

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2010/11/24 - Carolyn Compton, will give a featured presentation on “Those Biomarkers Come from Biospecimens: Garbage In, Garbage Out” at GTCbio’s 3rd Oncology Biomarkers Conference on January.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Carolyn Compton, Director of the NCI Office of Biorepositories and Biospecimen Research will give a featured presentation on “Those Biomarkers Come from Biospecimens: Garbage In, Garbage Out” at GTCbio’s 3rd Oncology Biomarkers Conference on January 27-28, 2011 in San Diego, CA

Dr. Compton will discuss how human biospecimens of sufficient quality are the principal sources of molecular data from patients. They are needed to meet the demands of the state-of-the-art analysis technologies that are essential for the accurate identification of molecular targets for drug development, disease diagnosis, and prevention; characterization of biologic variations that determine drug efficacy and drug toxicity; identification of markers for susceptibility, screening, and reoccurrence; development of molecular-based disease taxonomies; elucidation of molecular mechanisms of disease; and validation of new therapeutics and diagnostics.

The increased molecular analysis capabilities of a technology-rich era have raised the bar for the quality of biospecimens to be analyzed and the biomolecular analytes (e.g., RNAs, DNA, chromatin, etc.) derived from them. Individual molecular species derived from the biospecimen must be of high, consistent quality to ensure that the molecular-analysis data is reliable. When the analytes (”biomarkers”) come from human biospecimens, the quality of the biospecimen itself is a precondition of derivative analyte quality.

Attendees will understand the following:

1) how pre-analytical variables change biospecimen molecular composition and quality;
2) how either can lead to misinterpretation of artifact as a biomarker;
2) how to approach a solution to these issues.

Dr. Compton currently holds several national and international leadership positions in professional organizations such as the College of American Pathologists, the Cancer and Leukemia Group B, the American Joint Committee on Cancer, and the American Society of Clinical Oncology. She is also a member of the editorial boards of Cancer, Biopreservation and Biobanking and Clinical Proteomics. In addition to human biospecimen science, her research interests include translational studies in colon cancer, pancreatic cancer and wound healing.

For more information visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Carolyn Compton of NCI to Speak At Oncology Biomarkers Conference on January 27-28 San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today